• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Forum Appoints Robert Spake as General Counsel

    3/3/26 9:00:00 AM ET
    $ETHZ
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ETHZ alert in real time by email

    PALM BEACH, Fla., March 3, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM), a digital asset platform modernizing capital markets through the tokenization of real-world assets on Ethereum, today announced the appointment of Robert Spake as the company's general counsel. Spake's deep legal expertise in capital markets, tokenization, and regulatory compliance strengthens Forum's leadership team and sharpens its focus on launching compliant, institutionally structured real-world asset products within evolving regulatory frameworks. 

    Forum logo (PRNewsfoto/ETHZilla Corporation)

    "Robert joins Forum at a pivotal moment and his expertise advising high-growth financial technology companies will be a tremendous asset as we continue to scale," said McAndrew Rudisill, chairman and chief executive officer of Forum. "His background in securities, regulatory response, and registered investment adviser compliance reinforces our governance foundation as we build a first-of-its-kind platform for tokenized real-world assets on Ethereum and bring more assets on-chain."

    Most recently, Spake served as senior director and head of litigation at financial technology firm Republic and as chief compliance officer of Republic Capital, a registered investment adviser. In those roles, he oversaw litigation strategy, regulatory responses, and compliance infrastructure across multiple financial technology business units.

    "Forum is at the forefront of bringing real-world assets into digital markets, and I am eager to join the company at such an important stage of its development," said Spake. "The company is well-positioned at the intersection of capital markets and digital infrastructure, and I look forward to supporting its continued success with a strong commitment to regulatory discipline and sound governance."

    Prior to his role at Republic, Spake served as a shareholder in Polsinelli's Business Litigation Department, where he represented public and private clients in all phases of litigation. Earlier, Spake practiced at Weil, Gotshal & Manges LLP, where he counseled company boards of directors and senior management regarding corporate governance and business and regulatory matters. He began his legal career as a law clerk in the Delaware Court of Chancery.

    About Forum

    Forum Markets, Incorporated (NASDAQ:FRMM) is a digital asset platform modernizing capital markets through the tokenization of institutional-grade real-world assets on Ethereum. The company structures and brings cash-generating assets onto blockchain-based infrastructure to unlock liquidity, broaden investor access, and enable more efficient primary issuance and secondary market activity. Forum integrates traditional asset management principles with scalable digital market architecture as it builds a new framework for how real-world value is originated, accessed, and traded. For more information, visit Forum-Markets.com.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/forum-appoints-robert-spake-as-general-counsel-302702179.html

    SOURCE Forum Markets

    Get the next $ETHZ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ETHZ
    $FRMM

    CompanyDatePrice TargetRatingAnalyst
    More analyst ratings

    $ETHZ
    $FRMM
    SEC Filings

    View All

    ETHZilla Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - FORUM MARKETS Inc (0001690080) (Filer)

    2/26/26 4:30:29 PM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ETHZilla Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ETHZilla Corp (0001690080) (Filer)

    2/12/26 4:30:27 PM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by ETHZilla Corporation

    SCHEDULE 13G/A - ETHZilla Corp (0001690080) (Subject)

    2/9/26 5:11:40 PM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ETHZ
    $FRMM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Forum Announces Fourth Quarter and Year-End 2025 Earnings Release Date and Webcast Details

    PALM BEACH, Fla., March 4, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM), a digital asset platform modernizing capital markets through the tokenization of real-world assets on Ethereum, today announced it expects to release its financial results for the fourth quarter and year ended December 31, 2025, before the U.S. markets open on Tuesday, March 31, 2026. McAndrew Rudisill, chairman and chief executive officer, and John Saunders, chief financial officer, will host a live webcast on the same day at 10:30 a.m. EDT, to discuss fourth quarter results and operation

    3/4/26 9:00:00 AM ET
    $ETHZ
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Appoints Robert Spake as General Counsel

    PALM BEACH, Fla., March 3, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM), a digital asset platform modernizing capital markets through the tokenization of real-world assets on Ethereum, today announced the appointment of Robert Spake as the company's general counsel. Spake's deep legal expertise in capital markets, tokenization, and regulatory compliance strengthens Forum's leadership team and sharpens its focus on launching compliant, institutionally structured real-world asset products within evolving regulatory frameworks.  "Robert joins Forum at a pivotal mo

    3/3/26 9:00:00 AM ET
    $ETHZ
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ETHZilla Becomes Forum in Next Step of Strategic Evolution Toward Institutional-Grade Real-World Asset Tokenization

    Company Expects to Begin Trading on Nasdaq Under New Ticker Symbol "FRMM" on March 2, 2026PALM BEACH, Fla., Feb. 25, 2026 /PRNewswire/ -- ETHZilla Corporation (NASDAQ:ETHZ) today announced that it has updated its corporate name and brand to Forum Markets, Incorporated, doing business as Forum, and that, subject to approval by Nasdaq, its common stock is expected to begin trading on The Nasdaq Capital Market under the ticker symbol "FRMM" upon market open on March 2, 2026. The company's CUSIP number will remain unchanged, and no action is required from stockholders in relation to this change.

    2/25/26 9:00:00 AM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ETHZ
    $FRMM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Smith Ryan Lewis disposed of 16,718 shares (SEC Form 4)

    4 - ETHZilla Corp (0001690080) (Issuer)

    2/20/26 4:15:22 PM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New insider Edwards Michael A claimed no ownership of stock in the company (SEC Form 3)

    3 - ETHZilla Corp (0001690080) (Issuer)

    1/21/26 5:12:45 PM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form 4 filed by Director Suckling Andrew P

    4/A - ETHZilla Corp (0001690080) (Issuer)

    12/3/25 7:57:05 PM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ETHZ
    $FRMM
    Leadership Updates

    Live Leadership Updates

    View All

    Forum Appoints Robert Spake as General Counsel

    PALM BEACH, Fla., March 3, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM), a digital asset platform modernizing capital markets through the tokenization of real-world assets on Ethereum, today announced the appointment of Robert Spake as the company's general counsel. Spake's deep legal expertise in capital markets, tokenization, and regulatory compliance strengthens Forum's leadership team and sharpens its focus on launching compliant, institutionally structured real-world asset products within evolving regulatory frameworks.  "Robert joins Forum at a pivotal mo

    3/3/26 9:00:00 AM ET
    $ETHZ
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ETHZilla Announces Appointment of Angela Dalton and Michael Edwards to Board of Directors

    PALM BEACH, Fla., Dec. 19, 2025 /PRNewswire/ -- ETHZilla Corporation (NASDAQ:ETHZ) ("ETHZilla" or the "Company") today announced that Angela Dalton, chief executive officer and founder of Signum Growth and a veteran technology and media executive, and Michael Edwards, an accomplished institutional investor and strategic advisor, have been appointed to its board as independent directors, effective immediately. "Expanding and diversifying our board strengthens our ability to manage risk, evaluate capital allocation decisions and uphold strong governance standards," said McAndrew

    12/19/25 9:03:00 AM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ETHZilla names John Kristoff as SVP, Corporate Communications and Investor Relations

    PALM BEACH, Fla., Oct. 16, 2025 /PRNewswire/ -- ETHZilla Corporation (NASDAQ:ETHZ), a leading technology company connecting traditional finance with decentralized finance, today announced the appointment of John D. Kristoff as Senior Vice President, Corporate Communications and Investor Relations. He will report directly to Chairman and CEO McAndrew Rudisill. In this newly created role, Kristoff will lead ETHZilla's communications and investor relations strategies, shaping the company's narrative and deepening engagement with both the media and investors. He will also play a k

    10/16/25 8:00:00 AM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ETHZ
    $FRMM
    Financials

    Live finance-specific insights

    View All

    ETHZilla Integrates Karus to Power AI-Modeled Auto Loan Tokenization

    Strategic transaction seeks to combine Karus's predictive credit analytics with ETHZilla's blockchain infrastructure to bring real-world credit investments on-chain PALM BEACH, Fla., Dec. 3, 2025 /PRNewswire/ -- ETHZilla Corporation (NASDAQ:ETHZ) ("ETHZilla" or the "Company"), a technology company bringing decentralized finance infrastructure to traditional finance, today announced the acquisition of a 20% fully-diluted interest in Karus, Inc. ("Karus"), a leading artificial intelligence (AI) platform for auto finance decisioning and portfolio analytics. Pursuant to the transaction, ETHZilla plans to integrate Karus's AI-driven underwriting into its blockchain infrastructure, enabling the to

    12/3/25 8:00:00 AM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ETHZilla Reports Third Quarter 2025 Financial Results

    Company generates $4.1 million in revenue in first six weeks operating as ETHZilla; Accelerates RWA tokenization initiatives PALM BEACH, Fla., Nov. 14, 2025 /PRNewswire/ -- ETHZilla Corporation (NASDAQ:ETHZ) ("ETHZilla" or the "Company"), a technology company connecting traditional finance and decentralized finance (DeFi), today announced financial results for the third quarter ended September 30, 2025. Management Commentary "This quarter marked a transformative leap for ETHZilla, establishing us as a technology leader in DeFi and positioning us for real-world asset (RWA) toke

    11/14/25 8:00:00 AM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care